INNOVENT BIO (01801) granted 59,800 stock options and 583,700 restricted shares.
Xinda Biopharmaceutical (01801) announced that on September 1, 2026, the company granted 59,800 stock options to 9 grantees and awarded 583,700 restricted shares to 63 grantees in accordance with the terms of the 2024 share plan, pending acceptance by the grantees. Among the granted stock options and restricted shares, 1,837 stock options and 5,206 restricted shares have been awarded to non-executive director Mr. Xi.
INNOVENT BIO (01801) announced that on September 1, 2026, the company granted 59,800 stock options to 9 grantees and 583,700 restricted shares to 63 grantees under the terms of the 2024 Share Plan, subject to acceptance by the grantees. Among the stock options and restricted shares granted, 1,837 stock options and 5,206 restricted shares have been awarded to non-executive director Mr. Xi.
Related Articles
After doubling in two days, it surged again! GoPro (GPRO.US) saw an intraday increase of 85% as it merges with Starman Optical to venture into AI optical communication.
US Stock Market Move | Shares of optical communication concept stocks generally fell, with Lumentum (LITE.US) down over 5%.
CONTIOCEAN (02613): Successfully acquired the assets located in Jiangsu through public bidding.
After doubling in two days, it surged again! GoPro (GPRO.US) saw an intraday increase of 85% as it merges with Starman Optical to venture into AI optical communication.
US Stock Market Move | Shares of optical communication concept stocks generally fell, with Lumentum (LITE.US) down over 5%.
CONTIOCEAN (02613): Successfully acquired the assets located in Jiangsu through public bidding.
RECOMMEND
